These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23649769)

  • 1. Hepatocellular carcinoma and liver cirrhosis TP53 mutation analysis reflects a moderate dietary exposure to aflatoxins in Espírito Santo State, Brazil.
    de Carvalho FM; de Almeida Pereira T; Gonçalves PL; Jarske RD; Pereira FE; Louro ID
    Mol Biol Rep; 2013 Aug; 40(8):4883-7. PubMed ID: 23649769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from The Gambia.
    Kirk GD; Camus-Randon AM; Mendy M; Goedert JJ; Merle P; Trépo C; Bréchot C; Hainaut P; Montesano R
    J Natl Cancer Inst; 2000 Jan; 92(2):148-53. PubMed ID: 10639517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of plasma TP53 249Ser-mutated DNA by electrospray ionization mass spectrometry.
    Lleonart ME; Kirk GD; Villar S; Lesi OA; Dasgupta A; Goedert JJ; Mendy M; Hollstein MC; Montesano R; Groopman JD; Hainaut P; Friesen MD
    Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2956-62. PubMed ID: 16365016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
    Szymañska K; Chen JG; Cui Y; Gong YY; Turner PC; Villar S; Wild CP; Parkin DM; Hainaut P
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1638-43. PubMed ID: 19366907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 249 TP53 mutation has high prevalence and is correlated with larger and poorly differentiated HCC in Brazilian patients.
    Nogueira JA; Ono-Nita SK; Nita ME; de Souza MM; do Carmo EP; Mello ES; Scapulatempo C; Paranaguá-Vezozzo DC; Carrilho FJ; Alves VA
    BMC Cancer; 2009 Jun; 9():204. PubMed ID: 19558663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma.
    Kirk GD; Lesi OA; Mendy M; Szymañska K; Whittle H; Goedert JJ; Hainaut P; Montesano R
    Oncogene; 2005 Sep; 24(38):5858-67. PubMed ID: 16007211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma 249Ser p53 mutation in patients with hepatocellular carcinoma residing in a high risk area.
    Dong-Dong L; Xi-Ran Z
    J Cell Mol Med; 2003; 7(1):89-92. PubMed ID: 12767266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Codon 249 mutation in exon 7 of p53 gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China.
    Huang XH; Sun LH; Lu DD; Sun Y; Ma LJ; Zhang XR; Huang J; Yu L
    World J Gastroenterol; 2003 Apr; 9(4):692-5. PubMed ID: 12679912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of the mutation in codon 249 of the P53 gene in patients with hepatocellular carcinoma (HCC) in Turkey.
    Ozdemir FT; Tiftikci A; Sancak S; Eren F; Tahan V; Akın H; Gündüz F; Kedrah AE; Ustündağ Y; Avşar E; Tözün N; Ozdoğan O
    J Gastrointest Cancer; 2010 Sep; 41(3):185-9. PubMed ID: 20306157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ser-249 TP53 and CTNNB1 mutations in circulating free DNA of Egyptian patients with hepatocellular carcinoma versus chronic liver diseases.
    Hosny G; Farahat N; Tayel H; Hainaut P
    Cancer Lett; 2008 Jun; 264(2):201-8. PubMed ID: 18313840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aflatoxin-induced TP53 R249S mutation in hepatocellular carcinoma in Thailand: association with tumors developing in the absence of liver cirrhosis.
    Villar S; Ortiz-Cuaran S; Abedi-Ardekani B; Gouas D; Nogueira da Costa A; Plymoth A; Khuhaprema T; Kalalak A; Sangrajrang S; Friesen MD; Groopman JD; Hainaut P
    PLoS One; 2012; 7(6):e37707. PubMed ID: 22675488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of aflatoxin, mutant P53 gene and sIL-2 receptor in liver cirrhosis and hepatocellular carcinoma.
    El-Shanawani FM; Abdel-Hadi AA; Abu Zikri NB; Ismail A; El-Ansary M; El-Raai A
    J Egypt Soc Parasitol; 2006 Apr; 36(1):221-39. PubMed ID: 16605112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of aflatoxin induced p53 mutation at codon 249 (R249s) in hepatocellular carcinoma patients with and without hepatitis B surface antigen (HBsAg).
    Chittmittrapap S; Chieochansin T; Chaiteerakij R; Treeprasertsuk S; Klaikaew N; Tangkijvanich P; Komolmit P; Poovorawan Y
    Asian Pac J Cancer Prev; 2013; 14(12):7675-9. PubMed ID: 24460352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Features of Aflatoxin-Associated Hepatocellular Carcinoma.
    Zhang W; He H; Zang M; Wu Q; Zhao H; Lu LL; Ma P; Zheng H; Wang N; Zhang Y; He S; Chen X; Wu Z; Wang X; Cai J; Liu Z; Sun Z; Zeng YX; Qu C; Jiao Y
    Gastroenterology; 2017 Jul; 153(1):249-262.e2. PubMed ID: 28363643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India.
    Katiyar S; Dash BC; Thakur V; Guptan RC; Sarin SK; Das BC
    Cancer; 2000 Apr; 88(7):1565-73. PubMed ID: 10738214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa.
    Bressac B; Kew M; Wands J; Ozturk M
    Nature; 1991 Apr; 350(6317):429-31. PubMed ID: 1672732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B and alterations of the p53 tumor suppressor gene in hepatocellular carcinoma.
    Goldblum JR; Bartos RE; Carr KA; Frank TS
    Am J Surg Pathol; 1993 Dec; 17(12):1244-51. PubMed ID: 8238731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ser-249TP53 mutation in tumour and plasma DNA of hepatocellular carcinoma patients from a high incidence area in the Gambia, West Africa.
    Szymańska K; Lesi OA; Kirk GD; Sam O; Taniere P; Scoazec JY; Mendy M; Friesen MD; Whittle H; Montesano R; Hainaut P
    Int J Cancer; 2004 Jun; 110(3):374-9. PubMed ID: 15095302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
    Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y
    Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low Frequency of Aflatoxin Induced TP53 Gene Codon 249 Mutation in Hepatocellular Carcinoma from Egyptian Patients Living in the Nile Delta Region.
    Mosbeh A; Abdelmaguid W; Ezzat S; Kohla M; Sultan MM; Abdel-Rahman MH
    Asian Pac J Cancer Prev; 2023 Sep; 24(9):3165-3168. PubMed ID: 37774068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.